Study into prophylaxis treatment meets key endpoints : vimar

Results showed a clinically meaningful prevention of bleeds in people with severe haemophilia A - News - PharmaTimes

Related Keywords

Anders Ullman , Dietmar Berger , Global Head Of Development , Swedish Orphan Biovitrum , Global Head , Sanofi , Prophylaxis ,